FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Jean-Pierre Mach

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Anatomy

Concepts & Ideas

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Stéphanie Corgnac; Laurent Derré; Jean-Pierre Mach; Rachel Perret; Pedro Romero; Daniel E Speiser; Kathrin Stirnemann; Maurice Zauderer; Lianjun Zhang; Alena Donda
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
Christel Larbouret; Jean-Pierre Mach; Bruno Robert; David Azria; Caroline Bascoul-Mollevi; Emmanuelle Campigna; Thierry Chardès; Mickaël Coelho; Nadège Gaborit; André Pèlegrin
In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.
Jean-Pierre Mach
Introduction to monoclonal antibodies.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Jean-Pierre Mach (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Stéphanie Corgnac; Laurent Derré; Jean-Pierre Mach; Rachel Perret; Pedro Romero; Daniel E Speiser; Kathrin Stirnemann; Maurice Zauderer; Lianjun Zhang; Alena Donda
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
Cancer immunology, immunotherapy : CII 2013;62(4):747-60.
2012: Christel Larbouret; Jean-Pierre Mach; Bruno Robert; David Azria; Caroline Bascoul-Mollevi; Emmanuelle Campigna; Thierry Chardès; Mickaël Coelho; Nadège Gaborit; André Pèlegrin
In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.
Neoplasia (New York, N.Y.) 2012;14(2):121-30.
2012: Jean-Pierre Mach
Introduction to monoclonal antibodies.
Cancer immunity 2012;12():11.
2011: Séverine Loisel; Pierre-Alain André; Josee Golay; Franz Buchegger; Jean Kadouche; Martine Cérutti; Luca Bologna; Marek Kosinski; David Viertl; Angelika Bischof Delaloye; Christian Berthou; Jean-Pierre Mach; Laurence Boumsell
Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia.
Molecular cancer 2011;10():42.
2008: Claire Germain; Emmanuelle Campigna; imed salhi; Sébastien Morisseau; Isabelle Navarro-Teulon; Jean-Pierre Mach; André Pèlegrin; Bruno Robert
Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein.
Protein engineering, design & selection : PEDS 2008;21(11):665-72.
2008: Kathrin Stirnemann; Jackeline F Romero; Lucia Baldi; Bruno Robert; Valérie Cesson; Gurdyal S Besra; Maurice Zauderer; Florian Wurm; Giampietro Corradin; Jean-Pierre Mach; H Robson MacDonald; Alena Donda
Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in mice.
The Journal of clinical investigation 2008;118(3):994-1005.
2007: Christel Larbouret; Bruno Robert; Isabelle Navarro-Teulon; Simon Thèzenas; Maha-Zohra Ladjemi; Sébastien Morisseau; Emmanuelle Campigna; Frédéric Bibeau; Jean-Pierre Mach; André Pèlegrin; David Azria
In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(11):3356-62.
2006: Valérie Cesson; Kathrin Stirnemann; Bruno Robert; Immanuel F Luescher; Thomas Filleron; Giampietro Corradin; Jean-Pierre Mach; Alena Donda
Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7422-30.
2006: Omar M Fattah; Sylvain M Cloutier; Christoph Kündig; Loyse M Felber; Christian M Gygi; Patrice Jichlinski; Hans-Jürg Leisinger; Eric Gauthier; Jean-Pierre Mach; David Deperthes
Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells.
International journal of cancer. Journal international du cancer 2006;119(10):2455-63.
2006: Franz Buchegger; Cristian Antonescu; Angelika Bischof Delaloye; Claudine Helg; Tibor J Kovacsovics; Marek Kosinski; Jean-Pierre Mach; Nicolas Ketterer
Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma.
British journal of cancer 2006;94(12):1770-6.
2005: Claire Germain; Christel Larbouret; Valérie Cesson; Alena Donda; Werner Held; Jean-Pierre Mach; André Pèlegrin; Bruno Robert
MHC class I-related chain A conjugated to antitumor antibodies can sensitize tumor cells to specific lysis by natural killer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7516-22.
2004: Franz Buchegger; Florence Adamer; Andreas O Schaffland; Marek Kosinski; Carine Grannavel; Yves M Dupertuis; Nicolas de Tribolet; Jean-Pierre Mach; Angelika Bischof Delaloye
Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts.
International journal of cancer. Journal international du cancer 2004;110(1):145-9.
2003: Alena Donda; Valérie Cesson; Jean-Pierre Mach; Giampietro Corradin; F James Primus; Bruno Robert
In vivo targeting of an anti-tumor antibody coupled to antigenic MHC class I complexes induces specific growth inhibition and regression of established syngeneic tumor grafts.
Cancer immunity 2003;3():11.
2002: Sylvain M Cloutier; Jair R Chagas; Jean-Pierre Mach; Christian M Gygi; Hans-Jürg Leisinger; David Deperthes
Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology.
European journal of biochemistry / FEBS 2002;269(11):2747-54.
2001: Yves M Dupertuis; M Vazquez; Jean-Pierre Mach; Nicolas de Tribolet; C Pichard; Daniel O Slosman; Franz Buchegger
Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Cancer research 2001;61(21):7971-7.
2001: M Houimel; P Schneider; Alexey V Terskikh; Jean-Pierre Mach
Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor.
International journal of cancer. Journal international du cancer 2001;92(5):748-55.
2001: C Wong; Robert Waibel; M Sheets; Jean-Pierre Mach; R Finnern
Human scFv antibody fragments specific for the epithelial tumour marker MUC-1, selected by phage display on living cells.
Cancer immunology, immunotherapy : CII 2001;50(2):93-101.
2001: Bruno Robert; Philippe Guillaume; Immanuel F Luescher; Marie-Agnès Doucey; Jean-Charles Cerottini; Pedro Romero; Jean-Pierre Mach
Redirecting anti-viral CTL against cancer cells by surface targeting of monomeric MHC class I-viral peptide conjugated to antibody fragments.
Cancer immunity 2001;1():2.
2001: M Houimel; IE Corthesy-Theulaz; Igor Fisch; C Wong; B Corthesy; Jean-Pierre Mach; R Finnern
Selection of human single chain Fv antibody fragments binding and inhibiting Helicobacter pylori urease.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(1):36-44.
2000: Sylvain M Cloutier; S Couty; Alexey V Terskikh; L Marguerat; Valérie Crivelli; M Pugnières; J C Mani; Hans-Jürg Leisinger; Jean-Pierre Mach; David Deperthes
Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin.
Molecular immunology 2000;37(17):1067-77.
2000: André Pèlegrin; Françoise Xavier; Jacques Barbet; J Bartholeyns; Daniel Baty; Franz Buchegger; Jean-François Chatal; F Dufief; D Gurreau; Anne Gruaz-Guyon; D Lamotte; Lee Leserman; Jean-Pierre Mach; Bruno Robert; J C Saccavini; J L Teillaud; Isabelle Teulon
[Immunotargeting of tumors: state of the art and prospects in 2000].
Bulletin du cancer 2000;87(11):777-91.
2000: Bruno Robert; Philippe Guillaume; Immanuel F Luescher; Pedro Romero; Jean-Pierre Mach
Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes.
European journal of immunology 2000;30(11):3165-70.
2000: B B Vuagnat; Jean-Pierre Mach; J M Le Doussal
Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.
Molecular immunology 2000;37(8):467-78.
2000: Franz Buchegger; A Roth; Abdelkarim S Allal; Yves M Dupertuis; Daniel O Slosman; Angelika Bischof Delaloye; Jean-Pierre Mach
Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy.
Annals of the New York Academy of Sciences 2000;910():263-9; discussion 269-70.
2000: Franz Buchegger; Abdelkarim S Allal; A Roth; Jean-Pierre Papazyan; Yves M Dupertuis; René-Olivier Mirimanoff; Michel Gillet; Andre Pelegrin; Jean-Pierre Mach; Daniel O Slosman
Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study.
Anticancer research 2000;20(3B):1889-96.
1999: Robert Waibel; Roger Alberto; Jörg Willuda; R Finnern; Roger Schibli; A Stichelberger; André Egli; Ulrich Abram; Jean-Pierre Mach; Andreas Plückthun; P August Schubiger
Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex.
Nature biotechnology 1999;17(9):897-901.
1999: A Leconte; Véronique Garambois; Marc Ychou; Bruno Robert; Didier Pourquier; Alexey V Terskikh; Jean-Pierre Mach; André Pèlegrin
Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model.
British journal of cancer 1999;80(9):1373-9.
1999: M Houimel; Jean-Pierre Mach; Irène Corthésy-Theulaz; Blaise Corthésy; Igor Fisch
New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries.
European journal of biochemistry / FEBS 1999;262(3):774-80.
1999: P Escobar; Z Yu; Alexey V Terskikh; N Holmes; Giampietro Corradin; Jean-Pierre Mach; F Healy
Induction in transgenic mice of HLA-A2.1-restricted cytotoxic T cells specific for a peptide sequence from a mutated p21ras protein.
Clinical and experimental immunology 1999;116(2):214-9.
1999: Bruno Robert; Mylène Dorvillius; Franz Buchegger; Véronique Garambois; Jean-Claude Mani; M Pugnières; Jean-Pierre Mach; André Pèlegrin
Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA).
International journal of cancer. Journal international du cancer 1999;81(2):285-91.
1998: G Eberl; S Jiang; Z Yu; P Schneider; Giampietro Corradin; Jean-Pierre Mach
An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cells.
Clinical and experimental immunology 1998;114(2):173-8.
1998: P Westerman; Thomas Glanzmann; S Andrejevic; DR Braichotte; M Forrer; Georges Wagnieres; Philippe Monnier; Hubert van den Bergh; Jean-Pierre Mach; S Folli
Long circulating half-life and high tumor selectivity of the photosensitizer meta-tetrahydroxyphenylchlorin conjugated to polyethylene glycol in nude mice grafted with a human colon carcinoma.
International journal of cancer. Journal international du cancer 1998;76(6):842-50.
1998: Marc Ychou; Andre Pelegrin; P Faurous; Bruno Robert; J C Saccavini; D Guerreau; Jean-François Rossi; Michel Fabbro; Franz Buchegger; Jean-Pierre Mach; J C Artus
Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer.
International journal of cancer. Journal international du cancer 1998;75(4):615-9.
1997: Angelika Bischof Delaloye; B Delaloye; Franz Buchegger; CA Vogel; Michel Gillet; Jean-Pierre Mach; A Smith; P August Schubiger
Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(6):847-53.
1997: LQ Sun; CA Vogel; René-Olivier Mirimanoff; philippe coucke; Daniel O Slosman; Jean-Pierre Mach; Franz Buchegger
Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
Cancer research 1997;57(7):1312-9.
1997: Alexey V Terskikh; J M Le Doussal; R Crameri; Igor Fisch; Jean-Pierre Mach; Andrey V Kajava
"Peptabody": a new type of high avidity binding protein.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(5):1663-8.
1996: Bruno Robert; Jean-Pierre Mach; J C Mani; Marc Ychou; S Folli; J C Artus; André Pèlegrin
Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Cancer research 1996;56(20):4758-65.
1996: M C Galmiche; C A Vogel; Angelika Bischof Delaloye; P M Schmidt; F Healy; Jean-Pierre Mach; Franz Buchegger
Combined effects of interleukin-3 and interleukin-11 on hematopoiesis in irradiated mice.
Experimental hematology 1996;24(11):1298-306.
1996: C A Vogel; M C Galmiche; P Westermann; LQ Sun; André Pèlegrin; S Folli; A Bischof Delaloye; D O Slosman; Jean-Pierre Mach; Franz Buchegger
Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: a model for radioimmunotherapy.
International journal of cancer. Journal international du cancer 1996;67(2):294-302.
1996: Franz Buchegger; M Gillet; F Doenz; C A Vogel; C Achtari; Jean-Pierre Mach; B Delaloye; Angelika Bischof Delaloye
Biodistribution of anti-CEA F(ab')2 fragments after intra-arterial and intravenous injection in patients with liver metastases due to colorectal carcinoma.
Nuclear medicine communications 1996;17(6):500-3.
1996: Franz Buchegger; Jean-Pierre Mach; S Folli; B Delaloye; A Bischof-Delaloye; André Pèlegrin
Higher efficiency of 131I-labeled anti-carcinoembryonic antigen-monoclonal antibody F(ab')2 as compared to intact antibodies in radioimmunotherapy of established human colon carcinoma grafted in nude mice.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;141():19-35.
1995: Franz Buchegger; Jean-Pierre Mach; André Pèlegrin; M Gillet; C A Vogel; T Buclin; J E Ryser; B Delaloye; Angelika Bischof Delaloye
Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(3):420-9.
1994: Alexey V Terskikh; S Couty; André Pèlegrin; N Hardman; Walter Hunziker; Jean-Pierre Mach
Dimeric recombinant IgA directed against carcino-embryonic antigen, a novel tool for carcinoma localization.
Molecular immunology 1994;31(17):1313-9.
1994: J Z de Moraes; JL Gesztesi; P Westermann; J M Le Doussal; José Daniel Lopes; Jean-Pierre Mach
Anti-idiotypic monoclonal antibody AB3, reacting with the primary antigen (CEA), can localize in human colon-carcinoma xenografts as efficiently as AB1.
International journal of cancer. Journal international du cancer 1994;57(4):586-91.
1994: S Folli; P Westermann; DR Braichotte; André Pèlegrin; Georges Wagnières; Hubert van den Bergh; Jean-Pierre Mach
Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice.
Cancer research 1994;54(10):2643-9.
1994: Z Yu; F Healy; Danila Valmori; P Escobar; Giampietro Corradin; Jean-Pierre Mach
Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells.
International journal of cancer. Journal international du cancer 1994;56(2):244-8.
1993: C A Vogel; A Bischof-Delaloye; Jean-Pierre Mach; André Pèlegrin; N Hardman; B Delaloye; Franz Buchegger
Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
British journal of cancer 1993;68(4):684-90.
1993: Alexey V Terskikh; Jean-Pierre Mach; André Pèlegrin
Marked increase in the secretion of a fully antigenic recombinant carcinoembryonic antigen obtained by deletion of its hydrophobic tail.
Molecular immunology 1993;30(10):921-7.
1993: M Kurth; André Pèlegrin; K Rose; Robin E Offord; S Pochon; Jean-Pierre Mach; Franz Buchegger
Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor.
Journal of medicinal chemistry 1993;36(9):1255-61.
1993: S Folli; André Pèlegrin; Y Chalandon; X Yao; Franz Buchegger; D Lienard; F Lejeune; Jean-Pierre Mach
Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.
International journal of cancer. Journal international du cancer 1993;53(5):829-36.
1993: Marc Ychou; Marcel Ricard; Jean Lumbroso; P Rougier; Jean-Pierre Mach; F Buchegger; J C Saccavini; Philippe Lasser; D Elias; F Eschwege
Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues.
European journal of cancer (Oxford, England : 1990) 1993;29A(8):1105-11.
1992: J Z de Moraes; C R Carneiro; F Buchegger; Jean-Pierre Mach; José Daniel Lopes
Induction of an immune response through the idiotypic network with monoclonal anti-idiotype antibodies in the carcinoembryonic antigen system.
Journal of cellular biochemistry 1992;50(3):324-35.
1992: Y Chalandon; Jean-Pierre Mach; André Pèlegrin; S Folli; Franz Buchegger
Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.
Anticancer research 1992;12(4):1131-9.
1992: Jean-Pierre Mach; André Pèlegrin; S Folli; Franz Buchegger
[Radiolabeled monoclonal antibodies as anti-tumor missiles, their diagnostic success and therapeutic potential].
Bulletin de l'Académie nationale de médecine 1992;176(6):879-89.
1992: Franz Buchegger; André Pèlegrin; N Hardman; C Heusser; J Lukas; Wanda Dolci; Jean-Pierre Mach
Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-class in vivo.
International journal of cancer. Journal international du cancer 1992;50(3):416-22.
1991: Jean-Pierre Mach; André Pèlegrin; Franz Buchegger
Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors.
Current opinion in immunology 1991;3(5):685-93.
1991: Franz Buchegger; Y Chalandon; André Pèlegrin; N Hardman; Jean-Pierre Mach
Bone marrow dosimetry in rats using direct tissue counting after injection of radio-iodinated intact monoclonal antibodies or F(ab')2 fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(7):1414-21.
1991: André Pèlegrin; S Folli; Franz Buchegger; Jean-Pierre Mach; Georges Wagnières; Hubert van den Bergh
Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice.
Cancer 1991;67(10):2529-37.
1991: Gerrit Westera; H W Reist; Franz Buchegger; C H Heusser; N Hardman; A Pfeiffer; H L Sharma; Gustav K von Schulthess; Jean-Pierre Mach
Radioimmuno positron emission tomography with monoclonal antibodies: a new approach to quantifying in vivo tumour concentration and biodistribution for radioimmunotherapy.
Nuclear medicine communications 1991;12(5):429-37.
1990: Jean-Pierre Mach; F Buchegger; A Pelegrin; Marc Ychou; Marcel Ricard; J Lumbroso; P Rougier; P Lasser; D Elias; J C Saccavini
Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry study.
Pathologie-biologie 1990;38(8):819.
1990: Lucien Perey; Daniel F Hayes; C Tondini; G van Melle; J Bauer; T Lemarchand; M Reymond; Jean-Pierre Mach; Serge Leyvraz
Elevated CA125 levels in patients with metastatic breast carcinoma.
British journal of cancer 1990;62(4):668-70.
1990: Franz Buchegger; André Pèlegrin; B Delaloye; A Bischof-Delaloye; Jean-Pierre Mach
Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(6):1035-44.
1989: A Bischof-Delaloye; B Delaloye; Franz Buchegger; W Gilgien; A Studer; S Curchod; J C Givel; F Mosimann; J Pettavel; Jean-Pierre Mach
Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(10):1646-56.
1989: N Hardman; L L Gill; R F De Winter; K Wagner; M Hollis; F Businger; D Ammaturo; Franz Buchegger; Jean-Pierre Mach; C Heusser
Generation of a recombinant mouse-human chimaeric monoclonal antibody directed against human carcinoembryonic antigen.
International journal of cancer. Journal international du cancer 1989;44(3):424-33.
1989: S Pochon; Franz Buchegger; A Pélegrin; Jean-Pierre Mach; Robin E Offord; J E Ryser; K Rose
A novel derivative of the chelon desferrioxamine for site-specific conjugation to antibodies.
International journal of cancer. Journal international du cancer 1989;43(6):1188-94.
1989: M Audette; S Carrel; D Hayoz; L Giuffrè; Jean-Pierre Mach; L C Kühn
A novel interferon-gamma regulated human melanoma-associated antigen, gp33-38, defined by monoclonal antibody Me14-D12. II. Molecular cloning of a genomic probe.
Molecular immunology 1989;26(6):515-22.
1989: Franz Buchegger; C Pfister; K Fournier; F Prevel; M Schreyer; S Carrel; Jean-Pierre Mach
Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
The Journal of clinical investigation 1989;83(5):1449-56.
1989: I G Barr; S Miescher; V von Fliedner; Franz Buchegger; C Barras; A Lanzavecchia; Jean-Pierre Mach; S Carrel
In vivo localization of a bispecific antibody which targets human T lymphocytes to lyse human colon cancer cells.
International journal of cancer. Journal international du cancer 1989;43(3):501-7.
1988: L Giuffré; P Isler; Jean-Pierre Mach; S Carrel
A novel IFN-gamma regulated human melanoma associated antigen gp33-38 defined by monoclonal antibody Me14/D12. I. Identification and immunochemical characterization.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(6):2072-8.
1988: L Giuffrè; M Schreyer; Jean-Pierre Mach; S Carrel
Cyclic AMP induces differentiation in vitro of human melanoma cells.
Cancer 1988;61(6):1132-41.
1988: Franz Buchegger; A Vacca; S Carrel; M Schreyer; Jean-Pierre Mach
Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model.
International journal of cancer. Journal international du cancer 1988;41(1):127-34.
1988: A Vacca; Franz Buchegger; S Carrel; Jean-Pierre Mach
Imaging of human leukemic T-cell xenografts in nude mice by radiolabeled monoclonal antibodies and F(ab')2 fragments.
Cancer 1988;61(1):58-67.
1987: M Audette; Franz Buchegger; M Schreyer; Jean-Pierre Mach
Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Molecular immunology 1987;24(11):1177-86.
1987: S Carrel; P Isler; S Salvi; L Giuffrè; G Pantaleo; Jean-Pierre Mach; Jean-Charles Cerottini
Identification of a novel 45-kDa cell surface molecule involved in activation of the human Jurkat T cell line.
European journal of immunology 1987;17(10):1395-402.
1987: S Carrel; Jean-Pierre Mach; G Miescher; S Salvi; L Giuffrè; M Schreyer; P Isler
Phorbol 12-myristate 13-acetate induces surface expression of T3 on human immature T cell lines with and without concomitant expression of the T cell antigen receptor complex.
European journal of immunology 1987;17(8):1079-87.
1987: Jean-Pierre Mach; A Bischof-Delaloye; S Curchod; A Studer; J P Grob; J C Volant; F Mosimann; J C Givel; P Douglas; Serge Leyvraz
[Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy].
Schweizerische medizinische Wochenschrift 1987;117(29):1076-86.
1986: G A Losa; D Heumann; S Carrel; V von Fliedner; Jean-Pierre Mach
Characterization of membrane vesicles circulating in the serum of patients with common acute lymphoblastic leukemia.
Laboratory investigation; a journal of technical methods and pathology 1986;55(5):573-9.
1986: S Carrel; L Giuffrè; A Vacca; S Salvi; Jean-Pierre Mach; P Isler
Monoclonal antibodies against idiotypic determinant(s) of the T cell receptor from HPB-ALL cells induce IL2 production in Jurkat cells without apparent evidence of binding.
European journal of immunology 1986;16(7):823-8.
1986: S Carrel; P Isler; M Schreyer; A Vacca; S Salvi; L Giuffre; Jean-Pierre Mach
Expression on human thymocytes of the idiotypic structures (Ti) from two leukemia T cell lines Jurkat and HPB-ALL.
European journal of immunology 1986;16(6):649-52.
1986: C Girardet; A Vacca; A Schmidt-Kessen; M Schreyer; S Carrel; Jean-Pierre Mach
Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(4):1497-503.
1986: J P Grob; Jean-Pierre Mach; Franz Buchegger; M Schreyer; F Mosimann; A Besson; J Pettavel; V von Fliedner; A Bischof-Delaloye; B Delaloye
Cancer detection by immunoscintigraphy, selection, and clinical application of monoclonal anti-CEA antibodies and their F(ab')2 or Fab fragments.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1986;100():73-9.
1986: B Delaloye; A Bischof-Delaloye; Franz Buchegger; V von Fliedner; J P Grob; J C Volant; J Pettavel; Jean-Pierre Mach
Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
The Journal of clinical investigation 1986;77(1):301-11.
1985: V von Fliedner; J P Grob; D Heumann; S Carrel; Bernard Chapuis; Markus Fopp; P Imbach; F Cavalli; Jean-Pierre Mach
[Clinical characteristics of immature T-type (negative E-rosette) acute lymphoblastic leukemia detected by LAU-A1 monoclonal antibody].
Schweizerische medizinische Wochenschrift 1985;115(43):1515-6.
1985: D Heumann; S Carrel; A Morell; Alois Gratwohl; Markus Fopp; P Schneider; C Barras; Jean-Pierre Mach; V E von Fliedner
Heterogeneity of Ia antigen expression on myeloblastic leukaemias: correlation with stage of maturation defined by cytochemical markers.
British journal of haematology 1985;59(4):681-7.
1984: S Carrel; Franz Buchegger; Didier Heumann; C Girardet; C Barras; G Losa; Jean-Pierre Mach; V von Fliedner
Detection of the common acute lymphoblastic leukemia antigen in the serum of leukemia patients.
The Journal of clinical investigation 1984;74(5):1882-5.
1984: S Carrel; N Gross; Didier Heumann; R P Sekaly; C Girardet; A Schmidt-Kessen; Jean-Pierre Mach
Monoclonal antibody against a "Pan-T-cell" antigen expressed by thymocytes, peripheral T-lymphocytes and T-cell leukemias.
Molecular immunology 1984;21(10):831-40.
1983: C Girardet; S Ladisch; D Heumann; Jean-Pierre Mach; S Carrel
Identification by a monoclonal antibody of a glycolipid highly expressed by cells from the human myeloid lineage.
International journal of cancer. Journal international du cancer 1983;32(2):177-83.
1983: S Carrel; A Schmidt-Kessen; Jean-Pierre Mach; Didier Heumann; C Girardet
Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1983;130(5):2456-60.
1982: Eric Long; N Gross; C T Wake; Jean-Pierre Mach; S Carrel; R Accolla; Bernard Mach
Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line.
The EMBO journal 1982;1(5):649-54.
1982: S Carrel; M Schreyer; A Schmidt-Kessen; Jean-Pierre Mach
Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines.
Hybridoma 1982;1(4):387-97.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.